Cristina Csimma

CIK 1501623 · last filed 2024-02-13

Cristina Csimma is a corporate insider who has filed 21 SEC Form 4 insider transactions across 6 companies since 2011. The most recent filing, for PALI, was dated Feb 13, 2024. Current disclosed insider exposure totals $1.7K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.7K

Companies

6

Total Filings

21

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PALI Director 857 $2.02 $1.7K $0 4 2024-02-13
Aceragen, Inc. (IDRA) Delisted Director $7.22 $0 5 2022-06-27
PALISADE BIO, INC. (SNCA) Delisted Director $9.96 $0 2 2021-04-26
PALISADE BIO, INC. (CUR) Delisted Director $0 3 2019-10-11
JUNIPER PHARMACEUTICALS INC (JNP) Delisted Director 0 $0 4 2018-08-15
JUNIPER PHARMACEUTICALS INC (CBRX) Delisted Director 129,261 $0 3 2013-05-03

Recent Filings

21 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-02-13 PALI Exer (M) +12,800 $0 EDGAR
2023-11-24 PALI Grant (A) $0 EDGAR
2023-06-13 PALI Grant (A) $0 EDGAR
2022-06-27 Aceragen, Inc. (IDRA) Delisted Grant (A) $0 EDGAR
2022-02-10 PALI Grant (A) $0 EDGAR
2021-06-10 Aceragen, Inc. (IDRA) Delisted Grant (A) $0 EDGAR
2021-04-26 PALISADE BIO, INC. (SNCA) Delisted Grant (A) $0 EDGAR
2020-05-19 Aceragen, Inc. (IDRA) Delisted Grant (A) $0 EDGAR
2020-04-07 PALISADE BIO, INC. (SNCA) Delisted Grant (A) $0 EDGAR
2019-10-11 PALISADE BIO, INC. (CUR) Delisted Grant (A) $0 EDGAR
Showing 110 of 21
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.